On November 5, CareDx fell 8.23% in Regular Trading, trading at $79.135 per share, with turnover of $48.3629 million.
The most recent publicly available catalyst tied to the stock remains its late-October earnings release and guidance increase, though that news does not directly explain the current session's decline.
CareDx previously reported third-quarter adjusted EPS of $0.70 on revenue of $139.362 million, ahead of consensus estimates of $0.25 and $120.608 million, respectively. The company also raised full-year revenue guidance to $520 million-$530 million from $490 million-$500 million and lifted adjusted EBITDA guidance to $90 million-$100 million from $66 million-$78 million, with the new revenue range above the $495.1 million consensus expectation.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments